Melphalan hydrochloride and Kenalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Melphalan hydrochloride (melphalan hydrochloride) and Kenalog (triamcinolone acetonide). Common drug interactions include hypertension among females and basal cell carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Melphalan hydrochloride and Kenalog. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Melphalan hydrochloride?

Melphalan hydrochloride has active ingredients of melphalan hydrochloride. eHealthMe is studying from 3,970 Melphalan hydrochloride users. Check the latest studies of Melphalan hydrochloride.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

On Jul, 09, 2026

11 people who take Melphalan hydrochloride and Kenalog together, and have interactions are studied.

Melphalan hydrochloride and Kenalog drug interactions.

What are the common drug interactions of Melphalan Hydrochloride and Kenalog, by gender? *:

female:

Hypertension (high blood pressure)
Mass
Osteitis (a general term for inflammation of bone)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteonecrosis of jaw (death of bone of jaw)
Abscess jaw (tooth abscess or root abscess)
Activities of daily living impaired
Anxiety
Asthma
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

male:

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
Thrombocytopenia (decrease of platelets in blood)
White blood cell count decreased
Febrile neutropenia (fever with reduced white blood cells)

What are the common drug interactions of Melphalan Hydrochloride and Kenalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Anaemia (lack of blood)
Asthenia (weakness)
Abscess jaw (tooth abscess or root abscess)
Activities of daily living impaired
Anxiety
Asthma
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back disorder
Blepharitis (chronic inflammation of the eyelid)
Blood creatine phosphokinase increased

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 6 people, 54.55%
Multiple Myeloma (cancer of the plasma cells): 5 people, 45.45%
Immunodeficiency Disorders: 3 people, 27.27%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Melphalan hydrochloride and Kenalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously